BioStabilization Systems (BoSS)

Description

{"description":" The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence on ultra-cold conditions (-80 to -196˚C) for storage and transport. BoSS will yield a bioprocessing system that enables scalable production of thermally stable cells, paving the way for a new era of efficient and resilient manufacturing and distribution of biologics without any need for cold storage. BoSS-developed technologies will also accelerate many other avenues in biotechnology that directly impact healthcare, including bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, and wound repair, in addition to improving access to a wide range of existing biotherapeutics. \n\n Solution Summaries are required: \n\n For consideration as a Performer: \n\n \n\t Solution Summary due date: February 19th, 2026 5:00 PM ET \n \n\n For consideration as an IV&V partner: \n\n \n\t Solution Summary due date: April 17th, 2026 5:00 PM ET \n \n\n Interested parties are invited to review the attached BoSS Innovative Solutions Opening (ISO) ARPA-H -SOL-26-136. \n\n Submissions must be made to: \n\n \n\t Solution Summary Submission Site: https://solutions.arpa-h.gov/Submit-Solution/ \n \n\n Please ensure to follow this opportunity for any updates. \n\n For more information on the BoSS program visit: https://arpa-h.gov/explore-funding/programs/boss. \n\n For information on Proposer's Day details and registration information, please see Special Notice ARPA-H-SN-26-137. \n"} Solicitation Number: ARPA-H-SOL-26-136 Type: Solicitation Base Type: Solicitation NAICS: 541715 Classification Code: AN13 Response Deadline: 2026-03-26T17:00:00-04:00 Office Address: Washington, DC Place of Performance: Washington, District of Columbia, 20005 POC: SEE DESCRIPTION SECTION, do_NOT_use_THIS_email_ADDRESS@arpa-h.gov {"description":" The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence on ultra-cold conditions (-80 to -196˚C) for storage and transport. BoSS will yield a bioprocessing system that enables scalable production of thermally stable cells, paving the way for a new era of efficient and resilient manufacturing and distribution of biologics without any need for cold storage. BoSS-developed technologies will also accelerate many other avenues in biotechnology that directly impact healthcare, including bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, and wound repair, in addition to improving access to a wide range of existing biotherapeutics. \n\n Solution Summaries are required: \n\n For consideration as a Performer: \n\n \n\t Solution Summary due date: February 19th, 2026 5:00 PM ET \n \n\n For consideration as an IV&V partner: \n\n \n\t Solution Summary due date: April 17th, 2026 5:00 PM ET \n \n\n Interested parties are invited to review the attached BoSS Innovative Solutions Opening (ISO) ARPA-H -SOL-26-136. \n\n Submissions must be made to: \n\n \n\t Solution Summary Submission Site: https://solutions.arpa-h.gov/Submit-Solution/ \n \n\n Please ensure to follow this opportunity for any updates. \n\n For more information on the BoSS program visit: https://arpa-h.gov/explore-funding/programs/boss. \n\n For information on Proposer's Day details and registration information, please see Special Notice ARPA-H-SN-26-137. \n"}